1. Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial. Issue 5 (7th April 2017) Authors: Dyck, Peter J.; Kincaid, John C.; Dyck, P. James B.; Chaudhry, Vinay; Goyal, Namita A.; Alves, Christina; Salhi, Hayet; Wiesman, Janice F.; Labeyrie, Celine; Robinson‐Papp, Jessica; Cardoso, Márcio; Laura, Matilde; Ruzhansky, Katherine; Cortese, Andrea; Brannagan, Thomas H.; Khoury, Julie; Khella... Journal: Muscle & nerve Issue: Volume 56:Issue 5(2017) Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cutaneous Manifestations of Familial Transthyretin Amyloid Polyneuropathy. (October 2016) Authors: Lanoue, Julien; Wei, Nancy; Gorevic, Peter; Phelps, Robert G. Journal: American journal of dermatopathology Issue: Volume 38:Number 10(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Genetically transitional disease: a new concept in genomic medicine. Issue 2 (February 2023) Authors: Yao, Qingping; Gorevic, Peter; Shen, Bo; Gibson, Greg Journal: Trends in genetics Issue: Volume 39:Issue 2(2023) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy. (2nd January 2021) Authors: Gorevic, Peter; Franklin, Jaclyn; Chen, Jihong; Sajeev, Gautam; Wang, Jessie C. H.; Lin, Hollis Journal: Expert opinion on pharmacotherapy Issue: Volume 22:Number 1(2021) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021) Authors: Adams, David; Polydefkis, Michael; González-Duarte, Alejandra; Wixner, Jonas; Kristen, Arnt V; Schmidt, Hartmut H; Berk, John L; Losada López, Inés Asunción; Dispenzieri, Angela; Quan, Dianna; Conceição, Isabel M; Slama, Michel S; Gillmore, Julian D; Kyriakides, Theodoros; Ajroud-Driss, Senda; Wa... Journal: Lancet neurology Issue: Volume 20:Issue 1(2021) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021) Authors: Adams, David; Polydefkis, Michael; González-Duarte, Alejandra; Wixner, Jonas; Kristen, Arnt V; Schmidt, Hartmut H; Berk, John L; Losada López, Inés Asunción; Dispenzieri, Angela; Quan, Dianna; Conceição, Isabel M; Slama, Michel S; Gillmore, Julian D; Kyriakides, Theodoros; Ajroud-Driss, Senda; Wa... Journal: Lancet neurology Issue: Volume 20:Issue 1(2021) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis. (February 2019) Authors: Kristen, Arnt V; Ajroud-Driss, Senda; Conceição, Isabel; Gorevic, Peter; Kyriakides, Theodoros; Obici, Laura Journal: Neurodegenerative disease management Issue: Volume 9:Number 1(2019) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. (2nd July 2020) Authors: Obici, Laura; Berk, John L.; González-Duarte, Alejandra; Coelho, Teresa; Gillmore, Julian; Schmidt, Hartmut H.-J.; Schilling, Matthias; Yamashita, Taro; Labeyrie, Céline; Brannagan, Thomas H.; Ajroud-Driss, Senda; Gorevic, Peter; Kristen, Arnt V.; Franklin, Jaclyn; Chen, Jihong; Sweetser, Mariann... Journal: Amyloid Issue: Volume 27:Number 3(2020) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rituximab in Refractory and Relapsed Dermatomyositis and Polymyositis: Comment on the Article by Oddis et al. Issue 9 (26th August 2013) Authors: Cuttner, Janet; Spiera, Harry; Gorevic, Peter Journal: Arthritis and rheumatism Issue: Volume 65:Issue 9(2013:Sep.) Page Start: 2497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rituximab in Refractory and Relapsed Dermatomyositis and Polymyositis: Comment on the Article by Oddis et al. Issue 9 (26th August 2013) Authors: Cuttner, Janet; Spiera, Harry; Gorevic, Peter Journal: Arthritis and rheumatism Issue: Volume 65:Issue 9(2013:Sep.) Page Start: 2497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗